Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

HealthSource vs Lumora

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #31Desk pick
HealthSource

HealthSource is a telehealth weight-management platform offering compounded semaglutide and tirzepatide (injectable and oral sublingual) dispensed through a US-based FDA 503A licensed partner pharmacy.

Marked down on: No physician names or clinical leadership disclosed on public pages

vs
Dispatch #350
Lumora

Lumora (Blue Skies MD LLC dba Lumora MD) is a physician-founded telehealth platform offering compounded semaglutide and tirzepatide in injectable and sublingual forms.

Marked down on: Pricing is fully gated behind the assessment — no public pricing; actual monthly costs unverifiable without completing intake

HealthSource takes this head-to-head with the higher Desk Score, 84/100 (B) against 57/100 (C) for Lumora. Lumora still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

HealthSource

84/100

B

Overall

Lumora

57/100

C

Price transparency

94
30

State access

86
24

Molecule range

77
83

Onboarding speed

79
76

Support responsiveness

85
83

Licensing & trust

69
84

The spec sheet

FieldHealthSourceLumora
Semaglutide$199/mo (all doses, compounded)$199/mo (starting dose, plus a separate fee, compounded)
Tirzepatide$299/mo (all doses, compounded)$299/mo (starting dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-nameCompounded onlyCompounded only
Oral optionYesYes
Best forReaders who want compounded semaglutide or tirzepatide (injection or oral) in all 50 states from $199/mo.Readers who want adults wanting physician-led compounded GLP-1 care with labs, follow-up, and peptide options included.
Desk Score84/100B57/100C

The verdict

Desk pick — HealthSource

HealthSource takes this head-to-head with the higher Desk Score, 84/100 (B) against 57/100 (C) for Lumora. Lumora still holds its ground where its strengths line up with yours.

Choose HealthSource if…

Readers who want compounded semaglutide or tirzepatide (injection or oral) in all 50 states from $199/mo.

$199/mo (all doses, compounded) sema · $299/mo (all doses, compounded) tirz · All 50 states

Choose Lumora if…

Readers who want adults wanting physician-led compounded GLP-1 care with labs, follow-up, and peptide options included.

$199/mo (starting dose, plus a separate fee, compounded) sema · $299/mo (starting dose, compounded) tirz · Coverage not published

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: HealthSource · Lumora.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.